Relationship of oxidative enzymes with biochemical parameters in breast cancer patients
DOI:
https://doi.org/10.61841/28bbv551Keywords:
Breast Cancer, Antioxidant Enzymes, Biochemical Parameters, Liver-function enzymesAbstract
Background - Breast cancer has a complex aetiology. Significant breast cancer risk factors include age, food, obesity, inactivity, hormone replacement therapy, family history, and others. Our current study's objective was to evaluate the electrolyte and biochemical parameter values in both breast cancer patients and healthy individuals. We have also investigated the link between the antioxidant enzymes and levels of electrolytes.
Methods- The data came from 292 individuals who took part in closely supervised clinical research on the correlation between oxidative enzymes and biochemical indicators in breast cancer patients. Finding the connection between biochemical markers and oxidative enzymes in breast cancer patients was the goal of this open, non-randomized study.
Results- Aside from albumin, which has significantly increased in the healthy control patients (P = 0.04), no alterations in liver indicators like amylase and glucose were found. The most notable increases in K+, Ca2+, and PO43 were seen in patients with low baseline levels (P = 0.05). In the group of patients with breast cancer, it was also discovered that Na+ and PO43 increased significantly (P = 0.05).
Conclusion- Patients with breast cancer had elevated levels of YGT, LDH, ALP, urea, and phosphate, which might be employed as serum indicators for early identification of breast cancer. Antioxidant enzyme levels, on the other hand, were considerably lower in breast cancer patients.
Downloads
References
1. Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer. 2004;40(15):2293-2306.
2. Hong J, Woo HS, Kim H, et al. Anemia as a useful biomarker in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy. Cancer Sci. 2014;105(12):1569-1575.
3. Shaikh AJ, Bawany SA, Masood N, et al. Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia. J Cancer. 2011;2:62-66.
4. Field KM, Dow C, Michael M. Part I: Liver function in oncology: biochemistry and beyond. Lancet Oncol. 2008;9(11):1092-1101.
5. Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010;14(4):R147.
6. Penack O, Rempf P, Eisenblatter M, et al. Bloodstream infections in neutropenic patients: early detection of pathogens and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol. 2007;18(11):1870-1874.
7. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007;115:81-103.
8. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology: cancer and chemotherapy-induced anemia. NCCN, USA, vol 2, p 47. 2009.
9. Saulter KH, Acharia CR, Walters KS, et al. An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. PLoS One. 2008;3(4):e1908.
10. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47:469-484.
11. Schrijvers D. Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Clin Pharmacokinet. 2003;42(9):779-791.
12. Hadzic T, Aykin-Burns N, Zhu Y, et al. Paclitaxel combined with inhibitors of glucose, hydroperoxide metabolism enhances breast cancer cell killing via H2O2 mediated oxidative stress. Free Radic Biol Med. 2010;48:1024-1033.
13. Ilyasova D, Mixon G, Wang F, et al. Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration. Biomarkers. 2009;14(5):321-325.
14. Chala E, Manes C, Iliades H, Skaragkas G, Mouratidou D, Kapantais E. Insulin resistance, growth factors and cytokine levels in overweight women with breast cancer before and after chemotherapy. Hormones. 2006;5(2):137-146.
15. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford University, New York, 2007.
16. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-126.
17. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47:474-496.
18. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192-205.
19. Repetto M, Reides C, Carretero MLG, Costa M, Griemberg G, Llesuy S. Oxidative stress in blood of HIV infected patients. Clin Chim Acta. 1996;225:107-117.
20. Simao ANC, Suzukawa AA, Casado MF, Oliveira RD, Guarnier FA, Cecchini F. Genistein abrogates pre-hemolytic and oxidative stress damage induced by 2,2-azobis(amidinopropane). Life Sci. 2006;78:1202-1210.
21. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 1994;233:357-363.
22. Miller GL. Protein determination for large numbers of samples. Anal Chem. 1959;31:964.
23. Barbosa DS, Cecchini R, El Kadri MZ, Dichi I. Decrease oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition. 2003;19:837-841.
24. Fossey J, Lefort D, Sorba J. Free Radicals in Organic Chemistry. Wiley, New York, 1995.
25. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C1437.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
